Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
about
A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathyP2X7 Cell Death Receptor Activation and Mitochondrial Impairment in Oxaliplatin-Induced Apoptosis and Neuronal Injury: Cellular Mechanisms and In Vivo ApproachOxaliplatin-Induced Peripheral Neuropathy via TRPA1 Stimulation in Mice Dorsal Root Ganglion Is Correlated with Aluminum AccumulationAnticancer activity of methyl-substituted oxaliplatin analogs.Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in miceSensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.VGluT3⁺ primary afferents play distinct roles in mechanical and cold hypersensitivity depending on pain etiology.Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTRMultimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in miceDrosophila melanogaster: a new model to study cisplatin-induced neurotoxicity.Effect of L-carnitine Supplementation on Nutritional Status and Physical Performance Under Calorie Restriction.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.In Vitro and In Vivo Studies of Non-Platinum-Based Halogenated Compounds as Potent Antitumor Agents for Natural Targeted Chemotherapy of Cancers.Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.APE1, the DNA base excision repair protein, regulates the removal of platinum adducts in sensory neuronal cultures by NERClinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).A New Rat Model of Cisplatin-induced Neuropathic PainSickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expressionAttenuation of TRPV1 and TRPV4 Expression and Function in Mouse Inflammatory Pain Models Using Electroacupuncture.Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics folloPhlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis.Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesicsThe potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome.Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.Oxaliplatin-induced loss of phosphorylated heavy neurofilament subunit neuronal immunoreactivity in rat DRG tissue.Animal models of chemotherapy-evoked painful peripheral neuropathiesEffects of Taxol on Regeneration in a Rat Sciatic Nerve Transection ModelGlutathione alleviated peripheral neuropathy in oxaliplatin-treated mice by removing aluminum from dorsal root ganglia.Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl/6 mice.Immunosuppressive effects of opioids--clinical relevance.Calcium-permeable ion channels in pain signaling.The effects of N-acetylcysteine on cisplatin-induced cardiotoxicity on isolated rat hearts after short-term global ischemiaAnalgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.ANTI-NOCICEPTIVE EFFECT OF AGRIMONIA EUPATORIA EXTRACT ON A CISPLATIN-INDUCED NEUROPATHIC MODEL.Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors.Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanerCisplatin induced mitochondrial DNA damage in dorsal root ganglion neurons.Cisplatin induces mitochondrial deficits in Drosophila larval segmental nerve.
P2860
Q28484947-A6A12C3F-D44B-412F-9D33-38CAF541473DQ28534383-24577AA3-CEF6-4067-9A64-974933C3EA07Q28546867-AEF86D50-0F01-4959-93DA-6ECECCF16AB4Q30515979-29166D63-D933-4258-9BF0-3B17B4D14A6CQ33764113-E9CB1873-E790-450F-B553-997798F7C87EQ34412078-457DEF88-AB93-4B5E-A90C-66D34864A10DQ34430049-5D4A8514-F751-41A0-A9EC-287550752E0EQ34436798-49FF977B-6C9C-421A-AE38-1A3DCA2FD780Q34717624-1CC4A6E8-D229-4FD9-AE71-C05A0DB24A83Q35019148-58379B49-8ED6-4E59-95DD-BD61B5FC172DQ35090211-AD9A09D9-332F-4722-85FF-F75461E39522Q35365752-70ABF845-E7B9-4772-AA20-128BB9C3F350Q35740234-B4DCA1DE-8985-4A8F-82A0-CB1CB6EF28ACQ36001231-47B8BE78-6205-4C40-B8F3-794E18C39284Q36006338-B4F3E0E8-8EE8-4BC6-A81F-547F7A901921Q36011912-0C67B5D2-A811-474D-84B7-C069A019F8F4Q36162504-1F7270B5-EABB-4912-8A70-061DC4F5477FQ36177223-3E9DDE48-6256-42DC-8D70-D27D1FA50473Q36373009-18213C19-3CB0-4035-A4E8-EA3E1A6650C2Q36461898-C2488765-2A17-4062-A542-1CAAE3594842Q36476481-89DABC91-B623-40B5-BAA6-040D34E265C9Q36923747-0BE16CB4-83F5-4222-A9A0-9C578359ED60Q36991056-05F45C67-C7E3-4890-B63B-EE7B1E626A89Q37170634-B2F8AA8F-EB85-47EE-B194-C62C28DB9B34Q37279294-31C37501-F08E-4A9C-8B98-FEC29405E3D3Q37410573-E5635528-264C-4A35-B8EA-3C2C78EFCCC0Q37448398-8D4748AF-DCCC-4509-9547-D73719389860Q37605341-E28325A1-AE23-43A8-B8C3-F53DD6AE52CAQ37633265-B10C7B62-573B-455C-9C29-5871FA49ED9AQ37732947-70872ABF-1FD2-4A92-B0AB-1FD997EA0C49Q37734620-029E558B-B06D-4717-923E-9F3712D259A5Q37897497-E70AE285-0F7C-4369-8253-98C748D0BE83Q38175134-F6015BCF-58DA-481B-AA7E-70F55158A209Q41680108-C8E26D71-D5F3-4D15-AEB4-9BA6562AD16EQ41852990-6141CC5F-E8CC-4662-8EFC-7FA3C4280CA9Q42015870-BC66AE5F-6D4B-4F43-AEDA-9A70E8AA1ABCQ42027847-2BF622E8-2430-4A90-98FF-D75F000E087BQ42428424-58E2D826-8F7B-4283-BC8D-DB0802BF7F4EQ42586741-F21AB91F-0239-402F-8BBB-03097251B0EBQ46472909-31CCA200-9026-408B-8FA5-D09F6298ADE6
P2860
Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mice with cisplatin and oxalip ...... y responses to thermal stimuli
@en
Mice with cisplatin and oxalip ...... responses to thermal stimuli.
@nl
type
label
Mice with cisplatin and oxalip ...... y responses to thermal stimuli
@en
Mice with cisplatin and oxalip ...... responses to thermal stimuli.
@nl
prefLabel
Mice with cisplatin and oxalip ...... y responses to thermal stimuli
@en
Mice with cisplatin and oxalip ...... responses to thermal stimuli.
@nl
P2093
P2860
P356
P1433
P1476
Mice with cisplatin and oxalip ...... y responses to thermal stimuli
@en
P2093
Anthony J Windebank
Lauren E Ta
Philip A Low
P2860
P2888
P356
10.1186/1744-8069-5-9
P577
2009-02-26T00:00:00Z
P5875
P6179
1003009751